Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial.
Saved in:
| Title: | Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial. |
|---|---|
| Authors: | McMurray JJV (AUTHOR), Östergren J (AUTHOR), Swedberg K (AUTHOR), Granger CB (AUTHOR), Held P (AUTHOR), Michelson EL (AUTHOR), Olofsson B (AUTHOR), Yusuf S (AUTHOR), Pfeffer MA (AUTHOR), CHARM (Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity) Investigators and Committees (CORPORATE AUTHOR) |
| Source: | Lancet. 9/6/2003, Vol. 362 Issue 9386, p767-771. 5p. |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!